Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study.

Giovanni AdamiIrene GavioliMaurizio RossiniOmbretta ViapianaGiovanni OrsoliniCamilla BeniniEugenia BertoldoElena FracassiDavide GattiAngelo Fassio

Published in: Therapeutic advances in musculoskeletal disease (2022)

In conclusion, we found that all anti-osteoporotic medications considered in the study effectively reduced the risk of fracture in the real-life. The effect of bisphosphonate on fracture risk was apparent only after the first year of treatment. Our findings do not support the use of bisphosphonates in patients at imminent risk of fracture.

Keyphrases

hip fracture
bone mineral density
randomized controlled trial
systematic review
magnetic resonance imaging
computed tomography
postmenopausal women
combination therapy
body composition